SCHEMBL8618583

SCHEMBL8618583

C=CC(O)c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 1/20 0.50
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
LTA4H P09960 5/20 0.47
NR1H2 P55055 1/20 0.47
BAX Q07812 1/20 0.47
TSHR P16473 1/20 0.46
TGM2 P21980 1/20 0.45
HRH3 Q9Y5N1 1/20 0.43
MAOA P21397 1/20 0.42
ACACB O00763 1/20 0.41
ACACA Q13085 1/20 0.41
PARP10 Q53GL7 1/20 0.40
PLA2G2A P14555 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9492154 0.84 PTGS1 (0.53) SRD5A2CA1CA2LTA4HNR1H2
SCHEMBL8734331 0.81 SRC (0.43) SRD5A2TSHRHRH3
SCHEMBL3893413 0.81 TSHR (0.43) TSHR
Benzene SCHEMBL28196864 0.81 TSHR (0.43) TSHR
SCHEMBL13090620 0.81 TSHR (0.43) TSHR
SCHEMBL96576 0.81 TSHR (0.43) TSHR
SCHEMBL28306595 0.81 TSHR (0.43) TSHR
SCHEMBL8591731 0.81 SRD5A2 (0.54) SRD5A2CA1CA2LTA4HNR1H2
SCHEMBL9492536 0.81 LMNA (0.36) SRD5A2TGM2HRH3PARP10GAA
SCHEMBL11867493 0.80 SRD5A2 (0.46) SRD5A2CA1CA2LTA4HNR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712396-A PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS MAGNIN DAVID R (US) 1998-01-27 US disclosed
US-5567841-A ANTICHOLESTEROL AGENT BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-22 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed